Replies to post #67321 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

It speaks about response rates. Patients who do not show up in the response can still respond

Can not watch/listen right now, but if I understand your point I agree.

When people say "respond" they mean shrinking the tumour. But IO agents might very well be poor against bulk tumour while effective at preventing mets.

I think we need a rethink on what we mean by saying "respond to" a treatment.

I would not hold it against DCVax if it is poor wrt recist response rates, just like I do not hold the low response rates against PD-1s either.